OCIAD1 anticorps (C-Term)
Aperçu rapide pour OCIAD1 anticorps (C-Term) (ABIN631311)
Antigène
Voir toutes OCIAD1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- OCIAD1 antibody was raised against the C terminal of OCIAD1
-
Purification
- Affinity purified
-
Immunogène
- OCIAD1 antibody was raised using the C terminal of OCIAD1 corresponding to a region with amino acids QGPDPNLEESPKRKNITYEELRNKNRESYEVSLTQKTDPSVRPMHERVPK
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
OCIAD1 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this OCIAD1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of OCIAD1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- OCIAD1 (OCIA Domain Containing 1 (OCIAD1))
-
Autre désignation
- OCIAD1
-
Sujet
- OCIAD1 belongs to the OCIAD1 family. It contains 1 OCIA domain. OCIAD1 is over-expressed in metastatic ovarian cancer.
-
Poids moléculaire
- 27 kDa (MW of target protein)
Antigène
-